Elliott Advisors (UK) letter to GSK
The Pharma Data
JULY 6, 2021
At its Investor Update, GSK announced a package of new financial outlooks and ambitions. Adjusted operating margins are expected to improve from the current mid-20s level to over 30% by 2026. Cash generated from operations is expected to exceed £10 billion by 2026.
52 
Let's personalize your content